LifeMD Inc Ordinary Shares LFMD 深 沪
已收盘 08-01 16:00:00 美东时间
9.94
-0.470
-4.51%
华盛通- 最 高10.23
- 今 开10.14
- 成交量 110.24万股
- 最 低 9.805
- 昨 收 10.41
- 总市值 4.52亿
- 52周最高 15.84
- 市盈率 静 --
- 换手率 2.43%
- 52周最低 3.99
- 委 比 36.72%
- 总股本 4544.76万
- 历史最高 33.02
- 量 比 1.37
- 振 幅 4.08%
- 历史最低 1.14
- 每 手 1
- 风险率 2.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LifeMD Appoints Shayna Webb Dray as COO
LifeMD ( ($LFMD) ) has issued an announcement. On July 31, 2025, LifeMD announc...
08-01 05:15
LifeMD appoints chief operating officer
Shayna Webb Dray has been named chief executive officer of LifeMD (NASDAQ:LFMD), effective immediately. Source: Press release More on LifeMD LifeMD: Inflection Into Profitability Should Drive Stock Up...
07-31 20:52
LifeMD Names COO and Promotes Two Executives
LifeMD, Inc. announced the appointment of Shayna Webb Dray as Chief Operating Officer, recognizing her 15+ years of experience in operations and supply chain management. Webb Dray joined LifeMD in 2021, leading the supply chain strategy and successfully launching its weight management program. She expressed her commitment to enhancing patient experiences and operational excellence. Additionally, Jessica Friedeman was expanded to Chief Marketing a...
07-31 12:00
LifeMD to Report Second Quarter 2025 Financial Results on August 5
LifeMD, Inc. (Nasdaq: LFMD), a leading virtual primary care provider, will report its financial results for the first half of 2025 after U.S. markets close on August 5, 2025. A conference call will follow at 4:30 p.m. Eastern time. Interested parties can join via dial-in numbers (800-445-7795 toll-free, 785-424-1699 international) using conference ID LIFEMD or access a live webcast through the provided link. LifeMD offers telemedicine services, l...
07-29 20:05
美股大行评级 | 巴克莱上调 Robinhood目标价至102美元；瑞银下调京东目标价从58美元至50美元
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从25美元升至29美元；摩根士丹利：维持Legend Biotech"超配"评级，目标价从80美元升至81美元
07-11 09:04
Lake Street Maintains Buy on LifeMD, Raises Price Target to $18
Lake Street analyst Brooks O'Neil maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $12 to $18.
07-11 05:00
30%市值蒸发！诺和诺德“背刺”Hims & Hers Health
2025年伊始，Hims & Hers Health（下称”HIMS“）迎来了迄今为止表现最为强劲的开年季度。然而，6月23日，诺和诺德突然终止了与其关...
06-24 19:25
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD, Inc. announced that its Board of Directors has authorized a cash dividend of $0.5546875 per share to holders of its 8.875% Series A Cumulative Perpetual Preferred Stock. The dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. LifeMD is a leading provider of virtual primary care services, offering telemedicine, laboratory and pharmacy services, and specialized treatment across more than 20...
06-23 20:05
全球GLP-1渗透率翻三倍背后的诺和诺德红利
诺和诺德的表现明显逊色于礼来。有外国分析师认为，从最近的财务数据来看，诺和诺德的稳固地位和持续增长显而易见，而第三方研究也表明诺和诺德可触及的市场存在巨大机遇...
06-11 18:56
华盛早报丨中美关税谈判进展顺利！又一重磅A+H即将登场，“酱油茅”海天味业今起招股
美商务部长称中美谈判“进展顺利”！特斯拉股价触底三连涨，Robotaxi运营倒计时2天；又一重磅A+H即将登场，“酱油茅”海天味业今起招股>>
06-11 08:27
